Gavin is a second-year undergraduate from Massachusetts studying biochemistry. He joined the Swartz group in October 2017.
Gavin's research focuses on cancer immunotherapies.
Gavin is a second-year undergraduate from Massachusetts studying biochemistry. He joined the Swartz group in October 2017.
Gavin's research focuses on cancer immunotherapies.